📣 VC round data is live. Check it out!

Joint Valuation Multiples

Discover revenue and EBITDA valuation multiples for Joint and similar public comparables like Eureka Group Holdings, Radius Residential, DocGo, Biote and more.

Joint Overview

About Joint

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has one operating business segment; The Franchise Operations segment which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the Company’s franchise license, which represents symbolic intellectual property.


Founded

2010

HQ

United States

Employees

736

Financials (LTM)

Revenue: $57M
EBITDA: $13M

EV

$109M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Joint Financials

Joint reported last 12-month revenue of $57M and EBITDA of $13M.

In the same LTM period, Joint generated $46M in gross profit, $13M in EBITDA, and $2M in net income.

Revenue (LTM)


Joint P&L

In the most recent fiscal year, Joint reported revenue of $55M and EBITDA of $13M.

Joint is profitable as of last fiscal year, with gross margin of 80%, EBITDA margin of 24%, and net margin of 5%.

See analyst estimates for Joint
LTMLast FY202320242025202620272028
Revenue$57M$55M$118M$52M$55M
Gross Profit$46M$44M$107M$40M$44M
Gross Margin80%80%91%78%80%
EBITDA$13M$13M$9M$3M$808K
EBITDA Margin22%24%8%6%1%
EBIT Margin3%(2%)0%(3%)(2%)
Net Profit$2M$3M($10M)($9M)$3M
Net Margin4%5%(8%)(16%)5%

Financial data powered by Morningstar, Inc.

Joint Stock Performance

Joint has current market cap of $128M, and enterprise value of $109M.

Market Cap Evolution


Joint's stock price is $8.95.

Joint share price increased by 0.3% in the last 30 days, and decreased by 16.4% in the last year.

Joint has an EPS (earnings per share) of $0.20.

See more trading valuation data for Joint
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$109M$128M0.0%0.3%-3.2%-16.4%$0.20

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Joint Valuation Multiples

Joint trades at 1.9x EV/Revenue multiple, and 8.7x EV/EBITDA.

See NTM and 2027E valuation multiples for Joint

EV / Revenue (LTM)


Joint Financial Valuation Multiples

As of May 27, 2026, Joint has market cap of $128M and EV of $109M.

Joint has a P/E ratio of 59.8x.

LTMLast FY202320242025202620272028
EV/Revenue1.9x2.0x0.9x2.1x2.0x
EV/EBITDA8.7x8.4x11.9x36.5x134.8x
EV/EBIT70.2x(120.3x)194.7x(62.6x)(120.3x)
EV/Gross Profit2.4x2.5x1.0x2.7x2.5x
P/E59.8x43.9x(13.1x)(15.0x)43.9x
EV/FCF26.6x21.3x11.3x13.2xn/m

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Joint Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Joint Margins & Growth Rates

Joint grew revenue by 10% but EBITDA decreased by 8% in the last fiscal year.

In the most recent fiscal year, Joint reported gross margin of 80%, EBITDA margin of 24%, and net margin of 5%.

See estimated margins and future growth rates for Joint

Joint Margins

Last FY202420252026202720282029
Gross Margin80%78%80%82%
EBITDA Margin24%6%1%20%
EBIT Margin(2%)(3%)(2%)9%
Net Margin5%(16%)5%8%
FCF Margin9%16%1%4%

Joint Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth10%(56%)6%10%
Gross Profit Growth13%(62%)8%13%
EBITDA Growth(8%)(67%)(73%)1378%
EBIT Growth(679%)(411%)(48%)(679%)
Net Profit Growth68%(13%)(134%)68%
FCF Growth(50%)(15%)(96%)665%

Data powered by FactSet, Inc. and Morningstar, Inc.

Joint Operational KPIs

Joint's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Joint's Rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Joint's Rule of X is 44% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Joint
LTMLast FY202320242025202620272028
Rule of 4029%30%---
Bessemer Rule of X39%44%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue25%24%14%21%24%
G&A Expenses to Revenue50%54%69%57%54%
Opex to Revenue-81%91%81%81%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Eureka Group Holdings7.9x7.2x10.8x18.0x
Radius Residential1.8x1.5x10.4x8.7x
DocGo0.2x0.2x(1.9x)(2.6x)
Biote0.9x0.9x3.1x3.5x
P3 Health Partners0.2x0.2x(2.3x)(4.4x)
Third Age Health Services2.6x-11.1x-
Maternus-Kliniken1.7x-18.6x-
Oceania Healthcare4.4x3.3x16.8x16.6x

This data is available for Pro users. Sign up to see all Joint competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Joint

When was Joint founded?Joint was founded in 2010.
Where is Joint headquartered?Joint is headquartered in United States.
How many employees does Joint have?As of today, Joint has over 736 employees.
Who is the CEO of Joint?Joint's CEO is Sanjiv Kumar Razdan.
Is Joint publicly listed?Yes, Joint is a public company listed on Nasdaq.
What is the stock symbol of Joint?Joint trades under JYNT ticker.
When did Joint go public?Joint went public in 2014.
Who are competitors of Joint?Joint main competitors include Eureka Group Holdings, Radius Residential, DocGo, Biote, P3 Health Partners, Third Age Health Services, Maternus-Kliniken, Oceania Healthcare, Propel Funeral Partners, LNA Sante.
What is the current market cap of Joint?Joint's current market cap is $128M.
What is the current revenue of Joint?Joint's last 12 months revenue is $57M.
What is the current revenue growth of Joint?Joint revenue growth (NTM/LTM) is 7%.
What is the current EV/Revenue multiple of Joint?Current revenue multiple of Joint is 1.9x.
What is the current EBITDA of Joint?Joint's last 12 months EBITDA is $13M.
What is Joint's EBITDA margin?Joint's last 12 months EBITDA margin is 22%.
What is the current EV/EBITDA multiple of Joint?Current EBITDA multiple of Joint is 8.7x.
What is the current FCF of Joint?Joint's last 12 months FCF is $4M.
What is Joint's FCF margin?Joint's last 12 months FCF margin is 7%.
What is the current EV/FCF multiple of Joint?Current FCF multiple of Joint is 26.6x.
How many companies Joint has acquired to date?Joint hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Joint has invested to date?Joint hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Joint

Lists including Joint

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial